Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-09

Clinical Trial Update: Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing topical bromfenac to artificial tears for pain reduction after intravitreal injection has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artificial Tears
  • BROMFENAC (Bromfenac)

Snippet

Sponsor: Wills Eye | Conditions: Pain, Intravitreal Injection | Phase 4 | Status: COMPLETED